1211P A multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802)
H. Bando, S. Kumagai, D. Kotani, M. Saori, T. Habu, T. Tsushima, Harneet K. Hara, S. Kadowaki, K. Kato, K. Chin, K. Yamaguchi, S-I. Kageyama, H. Hojo, M. Nakamura, H. Tachibana, M. Wakabayashi, M. Fukutani, Nozomu Fuse, H. Nishikawa, T. Kojima
Topics & Concepts
MedicineAtezolizumabChemoradiotherapyEsophageal squamous cell carcinomaOncologyPhases of clinical researchInternal medicineCarcinomaChemotherapyCancerPembrolizumabImmunotherapyEsophageal Cancer Research and TreatmentCancer Immunotherapy and Biomarkers